AHA Scientific Sessions 2024 Industry Programming Guide

Event listings current as of Thursday, Oct. 25, 2024. Visit the Mobile Meeting Guide App for more details. 9 2024 INDUSTRY EVENTS GenePHIT: A Novel AAV Gene Therapy Trial in Congestive Heart Failure 1:30-2 p.m. CardioTalk II SUPPORTER: Asklepios BioPharmaceutical, Inc. Jardiance® (empagliflozin) Tablets: Expert Perspectives on Clinical Trial Data and Approved Indications 1:45-2:30 p.m. Learning Studio I SUPPORTER: Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA Lowering LDL-C for Very High-Risk ASCVD Patients: What You Need to Know 1:45-2:30 p.m. Learning Studio II SUPPORTER: Amgen Inc ViVE and Let Thrive: Revolutionizing Virtual Care With Equity at Heart 3-3:30 p.m. CardioTalk II SUPPORTER: AHA Center for Telehealth Coronary Inflammation: Shaping the Future of Long-Term Cardiovascular Risk Reduction 3:15-4 p.m. Learning Studio I SUPPORTER: Caristo Diagnostics Emerging Clinical Landscape in ATTR-CM 3:15-4 p.m. Learning Studio II SUPPORTER: BridgeBio Pharma, Inc. Saturday, Nov. 16

RkJQdWJsaXNoZXIy MjI2NjI=